Details for Patent: 6,342,515

✉ Email this page to a colleague

Summary for Patent: 6,342,515

Patent landscape, scope, and claims:

Title:	Remedy for neurodegenerative diseases
Abstract:	The present invention provides a medicament for neurodegenerative diseases comprising zonisamide or an alkali metal salt thereof as an active ingredient. The present medicament can be used in the prevention and treatment of neurodegenerative diseases such as Parkinson's disease, Huntington's disease, choreic syndrome and dystonic syndrome in mammals (including human).
Inventor(s):	Masuda; Yoshinobu (Katano, JP), Ochi; Yoshiaki (Sanda, JP)
Assignee:	Dainippon Pharmaceutical Co., Ltd. (Osaka-fu, JP)
Application Number:	09/582,433
Patent Claim Types: see list of patent claims	Use;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 6,342,515

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,342,515

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	9-369313	Dec 26, 1997

PCT Information
PCT Filed	December 21, 1998	PCT Application Number:	PCT/JP98/05757
PCT Publication Date:	July 08, 1999	PCT Publication Number:	WO99/33465

International Family Members for US Patent 6,342,515

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	297204	⤷ Subscribe
Canada	2317044	⤷ Subscribe
China	1149084	⤷ Subscribe
China	1283113	⤷ Subscribe
Germany	69830512	⤷ Subscribe
Denmark	1040830	⤷ Subscribe
European Patent Office	1040830	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.